- Treatment in symptomatic patients is anticoagulation with heparin and fluid resuscitation. Surgical exploration is reserved for patients with peritonitis
- in asymptomatic patients anticoagulation must be weighed against patient co-morbidities
- Hematologic assessment for hypercoagulable state is recommended
Wednesday, February 17, 2010
Thromboangitis obliterans
AKA Buerger's disease:
- chronic arterial inflammatory condition (can also affect veins)
- leads to arterial occlusion in medium and small extremity arteries
- Unknown etiology
- M>F
- complete abstinence from tobacco is the only known effective treatment
- cessation of tobacco can reduce rate by 50%
- chronic arterial inflammatory condition (can also affect veins)
- leads to arterial occlusion in medium and small extremity arteries
- Unknown etiology
- M>F
- complete abstinence from tobacco is the only known effective treatment
- cessation of tobacco can reduce rate by 50%
Monday, February 8, 2010
Phyllodes Tumor
· Varying malignant potential
· Round, may be indistinguishable from fibroadenoma
· Comprised of epithelial elements and connective tissue stroma (like a fibroadenoma)
Classification:
· Benign
· Borderline
· Malignant
· Based on cellular atypia
· Mitotic activity
· Overgorwth in stroma
· Phyllodes tumors have increased cellular activity compared to fibroadenomas
· If malignant treat with adjuvant therapy like a sarcoma
Treatment:
· Excise with a 1 cm margin of normal breast tissue
· Re-excision is often necessary to achieve this margin
· LN dissection is not necessary
· LN mets <5% of cases
· If LN mets to axilla then pt has a very poor prognosis
Saturday, February 6, 2010
Extracolonic manifestations of Ulcerative Colitis
Pyoderma gangrenosum
Erythema nodosum
Ankylosing spondylitis
Sclerosing cholangitis
Erythema nodosum
Ankylosing spondylitis
Sclerosing cholangitis
Tuesday, February 2, 2010
Left sided portal hypertension
From thrombosed splenic vein after pancreatitis.
- arterial inflow but no outflow.
- results in isolated gastric varices
Solution. NOT gastectomy
- splenectomy or angioembolizayion
- Posted from iPhone
- arterial inflow but no outflow.
- results in isolated gastric varices
Solution. NOT gastectomy
- splenectomy or angioembolizayion
- Posted from iPhone
Access to lessser sac
Paucher
Foramen of Winslow
Through transverse colon mesentery
Through stomach
Arid maneuver- mattox and come yo pancreas laterally at tail.
- Posted from iPhone
Foramen of Winslow
Through transverse colon mesentery
Through stomach
Arid maneuver- mattox and come yo pancreas laterally at tail.
- Posted from iPhone
Thursday, January 21, 2010
Management of Asymptomatic Gallstones
Few predictive factors for symptomatic progression of gallstone disease:
- Bariatric surgery - 30% develop gallstones
- post-colectomy - 20% will develop symptoms within 5 years
- prolonged TPN use
Despite these risk factors, there are few indications for prophylactic cholecystectomy:
- Expectant Management of Cholelithiasis is the accepted treatment despite low morbidity of lap chole
- Diabetes is not an indication for prophylactic chole. Diabetics do not have any significant difference in prevalence, presentation or complications compared to nondiabetics
Post-Transplantation:
- Cyclosporine leads to gallstone formation.
- Need for prophylactic chole has been shown to be of benefit in cardiac transplant patients if screening u/s shows stones (Milas et al, Mayo clinic)
- in renal transplant patients, majority (~90%) remain asymptomatic
Hemoglobinopathies:
- at risk of developing pigmented stones.
- sickle cell: 70% of pts
- hereditary spherocytosis: 85%
- thalassemia: 24%
- Gallstones in sickle cell patients can pose a problem. ~50% will become symptomatic within 3-5 years. Presence of gallstones can be diagnostically challenging due to possibility of abdominal sickling crisis.
- Hemoglobinopathies are an indication to perform prophylactic lap chole, lap chole should also be performed if doing a lap splenectomy
Bariatric Surgery:
- incidence of gallstone formation after rapid weight loss:
- general population: 10-20%
- bariatric surgery population: 30-40%
- if gallstones documented at time of bariatric surgery - lap chole recommended
- Ursodiol - can decrease incidence if patient compliant (prevents cholesterol absorption, expensive (~$1.50/d), BID). Suggested for patients undergoing bariatric surgery without prior evidence of stones.
Incidental Cholecystectomy - Controversial:
- During AAA: controversial due to the presence of graft material. Review of incidental chole - shown to be safe as long as performed after retroperitoneum is closed
- Other abdominal surgeries: One study (Watemberg et al) showed that in pts >70 yo with cholelithiasis, M&M was higher if you DO NOT do incidental chole during laparotomy for other reasons.... yet we do not routinely do this in practice - why?
- most were small studies - only Watemberg was larger study
- Bariatric surgery - 30% develop gallstones
- post-colectomy - 20% will develop symptoms within 5 years
- prolonged TPN use
Despite these risk factors, there are few indications for prophylactic cholecystectomy:
- Expectant Management of Cholelithiasis is the accepted treatment despite low morbidity of lap chole
- Diabetes is not an indication for prophylactic chole. Diabetics do not have any significant difference in prevalence, presentation or complications compared to nondiabetics
Post-Transplantation:
- Cyclosporine leads to gallstone formation.
- Need for prophylactic chole has been shown to be of benefit in cardiac transplant patients if screening u/s shows stones (Milas et al, Mayo clinic)
- in renal transplant patients, majority (~90%) remain asymptomatic
Hemoglobinopathies:
- at risk of developing pigmented stones.
- sickle cell: 70% of pts
- hereditary spherocytosis: 85%
- thalassemia: 24%
- Gallstones in sickle cell patients can pose a problem. ~50% will become symptomatic within 3-5 years. Presence of gallstones can be diagnostically challenging due to possibility of abdominal sickling crisis.
- Hemoglobinopathies are an indication to perform prophylactic lap chole, lap chole should also be performed if doing a lap splenectomy
Bariatric Surgery:
- incidence of gallstone formation after rapid weight loss:
- general population: 10-20%
- bariatric surgery population: 30-40%
- if gallstones documented at time of bariatric surgery - lap chole recommended
- Ursodiol - can decrease incidence if patient compliant (prevents cholesterol absorption, expensive (~$1.50/d), BID). Suggested for patients undergoing bariatric surgery without prior evidence of stones.
Incidental Cholecystectomy - Controversial:
- During AAA: controversial due to the presence of graft material. Review of incidental chole - shown to be safe as long as performed after retroperitoneum is closed
- Other abdominal surgeries: One study (Watemberg et al) showed that in pts >70 yo with cholelithiasis, M&M was higher if you DO NOT do incidental chole during laparotomy for other reasons.... yet we do not routinely do this in practice - why?
- most were small studies - only Watemberg was larger study
Subscribe to:
Posts (Atom)